Capitalmind
Capitalmind
Actionable insights on equities, fixed-income, macros and personal finance Start 14-Days Free Trial
Actionable investing insights Get Free Trial

Month: June 2016

1 / 10

Portfolio Review: Monsoon Portfolio Returns 9.59% in One Month

The Capital Mind Monsoon Portfolio At the start of the monsoons we have created the CM-Monsoon portfolio. The portfolio consists of the stocks which have ...
Portfolios-1.jpg

StratOptions: Brexit Helps Us Close The Month With 2.5%, June Edition Part 2

This time we took the volatility on the Brexit day to get a trade that made us a decent profit. Even though the market rebounded nearly 300 points, we didn't ...
optionalysisHeader.jpg

On Slack: 27/km day, Machine Beats Man, RBI coffers and much more…

The Slack Discussions The Slack group at Capital Mind Premium has been extremely active and if you haven’t been there (Premium subscribers only), pop us a ...
Slack-Logo2.png

DLF Promoter Stake Increase: How To Differentiate Rumour From Reality

Economic Times carried an article yesterday which took DLF shares up nearly 8%, because, goodness the promoter was going to pump in 10,000 cr. into the company ...
DLF-Chart.png

Video: How To Park Your Money, Save 80% Tax & Also Generate Cash Flow!

Capitalmind speaks of a new way to allocate a lumpsum cash amount and recover interest from it, every month and pay 80% less tax compared to a Fixed ...
maxresdefault-3.jpg

Banks: MCLR Update – June 30, 2016

As a follow-up note on MCLR (Marginal Cost of funds based Lending Rate) and how it is changing the way banks lend in India, we are publishing the rates of ...
MCLR-Update-June-2016.png

Sugar Stocks – The Multi Bagger of The Year!

The consumer are facing the bitter price of sugar, but the investors are enjoying the flavor of the sweet commodity. When the market was grappling with ...
Confectioners-Returns-Heat-Map-FY16.png

Tano Capital cuts stake in Shilpa Medicare on the heels of amalgamation with Navya Biologicals

Shilpa Medicare deals in high-quality Active Pharmaceutical Ingredients (APIs), Intermediates, Formulations, New Drug Delivery Systems, Peptides / Biotech ...
Shilpa-Medicare-Logo.png

Will Britain’s exit from Europe impact the Pharmaceutical Industry?

Yes. Remember this that UK on its own, represents 2.5% of the world pharmaceutical market (the market is over $1 trillion) and the market has not grown to this ...
United-Kingdom.png

Charts: Foreign Investors Are Quietly Exiting Debt Investments While Buying Stocks

Foreign Portfolio Investors (FPIs) have, in a strange way, sold a lot of debt, while continuing to buy equity. In June, while they sold a bit through the last ...
FPI-Investments-in-Debt.png